Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Omega Therapeutics Inc (NQ: OMGA ) 1.110 -0.020 (-1.77%) Streaming Delayed Price Updated: 2:56 PM EST, Nov 7, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Omega Therapeutics Inc < Previous 1 2 3 4 5 Next > 12 Health Care Stocks Moving In Thursday's Intraday Session October 05, 2023 Via Benzinga Omega Therapeutics to Present New Preclinical Data on OTX-2101 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics October 04, 2023 From Omega Therapeutics Via GlobeNewswire Omega Therapeutics' Cancer Program Shows Encouraging Anti Tumor Activity In Liver Cancer September 26, 2023 Omega Therapeutics Inc (NASDAQ: OMGA) announced preliminary data from the initial two dose level cohorts (n=8) from Part 1 of its Phase 1/2 MYCHELANGELO I study of OTX-2002 in hepatocellular carcinoma... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday September 26, 2023 Pre-market stock movers are among the biggest topics worth checking out on Tuesday and we have the latest news for investors! Via InvestorPlace Analyst Ratings for Omega Therapeutics May 08, 2023 Via Benzinga Omega Therapeutics: Q1 Earnings Insights May 04, 2023 Via Benzinga Analyst Expectations for Omega Therapeutics's Future March 31, 2023 Via Benzinga Omega Therapeutics Announces Promising Preliminary Clinical Data for OTX-2002 from Ongoing MYCHELANGELO™ I Trial September 26, 2023 From Omega Therapeutics Via GlobeNewswire Omega Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data for OTX-2002 from Ongoing MYCHELANGELO™ I Trial on September 26 September 25, 2023 From Omega Therapeutics Via GlobeNewswire Omega Therapeutics to Participate in Two Upcoming Investor Conferences September 21, 2023 From Omega Therapeutics Via GlobeNewswire Omega Therapeutics Announces Updates to its Board of Directors August 29, 2023 From Omega Therapeutics Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Pre-Market Session August 25, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session August 24, 2023 Via Benzinga Omega Therapeutics Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress August 03, 2023 From Omega Therapeutics Via GlobeNewswire Stocks That Hit 52-Week Lows On Friday August 11, 2023 During the Friday's sesion, 157 stocks hit new 52-week lows. Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session July 12, 2023 Via Benzinga Omega Therapeutics Appoints Chris Schade to its Board of Directors July 12, 2023 Accomplished Industry Veteran Brings Deep Strategic and Operational Expertise From Omega Therapeutics Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's Intraday Session July 04, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session July 03, 2023 Via Benzinga Omega Therapeutics to Participate in Two Upcoming Investor Conferences June 01, 2023 From Omega Therapeutics Via GlobeNewswire Omega Therapeutics Presents New Preclinical Data Demonstrating the Potential of Omega Epigenomic Controllers™ to Synergize with Immunotherapies at the ASCO 2023 Annual Meeting May 31, 2023 From Omega Therapeutics Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Pre-Market Session May 17, 2023 Via Benzinga Omega Therapeutics Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress May 04, 2023 From Omega Therapeutics Via GlobeNewswire Omega Therapeutics to Present New Preclinical Data at the American Society of Clinical Oncology 2023 Annual Meeting April 27, 2023 From Omega Therapeutics Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Intraday Session April 05, 2023 Via Benzinga Omega Therapeutics Announces Clinical Supply Agreement to Evaluate the Combination of OTX-2002 and Atezolizumab in Hepatocellular Carcinoma March 30, 2023 From Omega Therapeutics Via GlobeNewswire Why Bed Bath & Beyond Shares Are Trading Lower By Around 24%? Here Are Other Stocks Moving In Monday's Mid-Day Session March 20, 2023 Gainers Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 10, 2023 March 10, 2023 Via Benzinga Omega Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update March 01, 2023 From Omega Therapeutics Via GlobeNewswire Over $19M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying February 28, 2023 Although US stocks closed higher on Monday, there were a few notable insider trades. Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
